Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
USD 37.43
(0.0%)
USD 37.43
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 31.68 Billion JPY | -0.74% |
| 2022 | 31.86 Billion JPY | 2.54% |
| 2021 | 30.78 Billion JPY | 4.16% |
| 2020 | 29.91 Billion JPY | -1.48% |
| 2019 | 30.33 Billion JPY | 3.98% |
| 2018 | 29.59 Billion JPY | 10.93% |
| 2017 | 26.32 Billion JPY | 24.36% |
| 2016 | 22.4 Billion JPY | 6.44% |
| 2015 | 21.05 Billion JPY | -4.13% |
| 2014 | 21.01 Billion JPY | 0.35% |
| 2013 | 21.21 Billion JPY | 0.99% |
| 2012 | 19.87 Billion JPY | -28.39% |
| 2011 | 23.09 Billion JPY | 1.85% |
| 2010 | 29.7 Billion JPY | 6.07% |
| 2009 | 28 Billion JPY | 7.33% |
| 2008 | 26.09 Billion JPY | -3.77% |
| 2007 | 19.63 Billion JPY | -30.38% |
| 2006 | 38.94 Billion JPY | 4.4% |
| 2005 | 16.91 Billion JPY | 10.71% |
| 2004 | 33.69 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 5.51 Billion JPY | -30.0% |
| 2024 Q2 | 5.01 Billion JPY | -87.64% |
| 2023 Q2 | 6.04 Billion JPY | 15.79% |
| 2023 FY | - JPY | -0.74% |
| 2023 Q3 | 9.72 Billion JPY | 60.87% |
| 2023 Q4 | 6.52 Billion JPY | -32.9% |
| 2023 Q1 | 5.22 Billion JPY | -33.78% |
| 2022 FY | - JPY | 2.54% |
| 2022 Q2 | 5.83 Billion JPY | 13.28% |
| 2022 Q1 | 5.15 Billion JPY | -26.67% |
| 2022 Q4 | 7.88 Billion JPY | -17.8% |
| 2022 Q3 | 9.59 Billion JPY | 64.32% |
| 2021 FY | - JPY | 4.16% |
| 2021 Q4 | 7.02 Billion JPY | -29.43% |
| 2021 Q1 | 5.23 Billion JPY | -22.3% |
| 2021 Q2 | 5.93 Billion JPY | 13.44% |
| 2021 Q3 | 9.95 Billion JPY | 67.78% |
| 2020 FY | - JPY | -1.48% |
| 2020 Q4 | 6.73 Billion JPY | -32.98% |
| 2020 Q3 | 10.04 Billion JPY | 76.29% |
| 2020 Q2 | 5.69 Billion JPY | 12.06% |
| 2020 Q1 | 5.08 Billion JPY | -22.45% |
| 2019 FY | - JPY | 3.98% |
| 2019 Q4 | 6.55 Billion JPY | -33.2% |
| 2019 Q3 | 9.81 Billion JPY | 52.9% |
| 2019 Q2 | 6.42 Billion JPY | 22.92% |
| 2019 Q1 | 5.22 Billion JPY | -24.35% |
| 2018 Q1 | 5.41 Billion JPY | -26.17% |
| 2018 Q2 | 6.11 Billion JPY | 12.88% |
| 2018 FY | - JPY | 10.93% |
| 2018 Q4 | 6.9 Billion JPY | -23.87% |
| 2018 Q3 | 9.06 Billion JPY | 48.26% |
| 2017 Q4 | 7.34 Billion JPY | 8.63% |
| 2017 FY | - JPY | 24.36% |
| 2017 Q1 | 4.85 Billion JPY | 0.0% |
| 2017 Q2 | 5.39 Billion JPY | 11.14% |
| 2017 Q3 | 6.75 Billion JPY | 25.22% |
| 2016 FY | - JPY | 6.44% |
| 2016 Q2 | 7.14 Billion JPY | 407.02% |
| 2016 Q3 | 4.5 Billion JPY | -37.01% |
| 2016 Q1 | 1.41 Billion JPY | -80.88% |
| 2015 FY | - JPY | -4.13% |
| 2015 Q1 | 3.09 Billion JPY | -57.88% |
| 2015 Q4 | 7.37 Billion JPY | 61.55% |
| 2015 Q2 | 4.63 Billion JPY | 49.74% |
| 2015 Q3 | 4.56 Billion JPY | -1.55% |
| 2014 Q4 | 7.35 Billion JPY | 52.68% |
| 2014 Q2 | 3.6 Billion JPY | 10.45% |
| 2014 FY | - JPY | 0.35% |
| 2014 Q3 | 4.81 Billion JPY | 33.54% |
| 2014 Q1 | 3.26 Billion JPY | -51.09% |
| 2013 Q3 | 4.67 Billion JPY | 11.85% |
| 2013 Q4 | 6.67 Billion JPY | 42.85% |
| 2013 Q2 | 4.17 Billion JPY | 54.02% |
| 2013 Q1 | 2.71 Billion JPY | -61.97% |
| 2013 FY | - JPY | 0.99% |
| 2012 Q1 | 9.8 Billion JPY | 57.24% |
| 2012 Q2 | 3.8 Billion JPY | -61.18% |
| 2012 Q4 | 7.13 Billion JPY | 41.26% |
| 2012 Q3 | 5.04 Billion JPY | 32.66% |
| 2012 FY | - JPY | -28.39% |
| 2011 Q2 | 5.58 Billion JPY | -42.21% |
| 2011 Q4 | 6.23 Billion JPY | 15.38% |
| 2011 Q3 | 5.4 Billion JPY | -3.21% |
| 2011 FY | - JPY | 1.85% |
| 2011 Q1 | 9.66 Billion JPY | 29.3% |
| 2010 Q1 | 8.83 Billion JPY | 16.63% |
| 2010 Q2 | 5.7 Billion JPY | -35.44% |
| 2010 Q3 | 6.86 Billion JPY | 20.29% |
| 2010 FY | - JPY | 6.07% |
| 2010 Q4 | 7.47 Billion JPY | 8.86% |
| 2009 Q1 | 8.75 Billion JPY | 22.49% |
| 2009 Q3 | 5.98 Billion JPY | -18.18% |
| 2009 Q4 | 7.57 Billion JPY | 26.72% |
| 2009 FY | - JPY | 7.33% |
| 2009 Q2 | 7.3 Billion JPY | -16.48% |
| 2008 Q4 | 7.14 Billion JPY | 60.54% |
| 2008 FY | - JPY | -3.77% |
| 2008 Q3 | 4.45 Billion JPY | 0.0% |
| 2007 FY | - JPY | -30.38% |
| 2006 FY | - JPY | 4.4% |
| 2005 FY | - JPY | 10.71% |
| 2004 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | -77.49 Thousand USD | 40887956.498% |
| Bruush Oral Care Inc. | -4.9 Million USD | 645841.811% |
| CCA Industries, Inc. | -259.14 Thousand USD | 12226601.3% |
| DSwiss, Inc. | 20 Thousand USD | -158404059.584% |
| EOS, Inc. | -592.2 Thousand USD | 5350310.486% |
| Greyson International, Inc. | -75.91 Thousand USD | 41739001.331% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | 120 Thousand USD | -26403233.333% |
| Infusion Brands International, Inc. | -6.17 Million USD | 512965.753% |
| Mandom Corporation | 44.26 Million USD | -71485.608% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | -597.89 Thousand USD | 5299367.094% |
| Oliveda International, Inc. | -1.18 Million USD | 2666795.844% |
| PacificHealth Laboratories, Inc. | -430 Thousand USD | 7368437.822% |
| Prosperous Future Holdings Limited | -19.68 Million USD | 161046.866% |
| PURE Bioscience, Inc. | -3.04 Million USD | 1039942.468% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | -476.51 Thousand USD | 6649152.818% |
| Sentient Brands Holdings Inc. | -246.98 Thousand USD | 12828617.173% |
| Sunset Capital Assets, Inc. | -190.12 Thousand USD | 16664750.47% |
| The Stephan Co. | -124 Thousand USD | 25551712.903% |
| Turner Valley Oil & Gas, Inc. | -115.2 Thousand USD | 27501662.392% |
| Winning Brands Corporation | -267.95 Thousand USD | 11824694.141% |
| Warpaint London PLC | 26.02 Million USD | -121625.622% |
| Zoono Group Limited | -5.41 Million USD | 585420.471% |
| Zurvita Holdings, Inc. | -79.68 Thousand USD | 39762160.138% |